Lamictal for Anxiety: What the Research Shows Before You Try It

Maybe you’ve been on an SSRI that took the edge off but never quite settled things. Maybe your anxiety comes in waves that seem tied to your mood, or a friend said Lamictal changed everything for them. Lamictal is an epilepsy and bipolar medication first, and any effect on anxiety is still a question the research hasn’t fully answered.

Your brain constantly balances signals that excite nerve cells against signals that calm them. Lamotrigine works on the excitatory side. Its exact mechanism in mood disorders isn’t known, but according to the FDA prescribing information, it blocks voltage-sensitive sodium channels, which steadies nerve cell membranes and reduces the release of glutamate, the brain’s main “go” chemical. That makes anxiety relief plausible on paper, and deciding whether it applies to you takes precision about which kind of anxiety you have.

The established standard for anxiety disorders is well tested. A 2020 review of anxiety drugs names SSRIs and SNRIs as first-line drugs, based on treatment guidelines and meta-analyses of randomized trials, and notes that therapy works on its own or alongside medication. Those options have been tested in many randomized trials across generalized anxiety, panic, and social anxiety disorder. The results are real, and the science is well established.

But first-line treatment doesn’t fit everyone, and at Siggy we’d rather show you exactly where the evidence for an off-label option ends than let a hopeful forum thread fill in the gaps.

An evidence-mapped view sorts the lamotrigine research by anxiety type, because a positive trial in one condition says little about another. It also weighs the drug’s specific risks against what it might realistically offer you. That sorting comes from trial data rather than marketing, which makes the distinction one of evidence.

What This Page Covers

• What Is Lamictal Approved For?
• What the Research Shows for Anxiety
• Why Some People Feel Calmer on Lamictal
• When a Prescriber Might Consider It
• Why Lamictal Takes Weeks to Start
• Risks to Weigh Before Starting
• Questions to Ask Your Prescriber
• Get a Clear Read on Your Anxiety

What Is Lamictal Approved For?

Lamictal (lamotrigine) has two FDA-approved uses. The label covers several seizure types in epilepsy, and maintenance treatment of bipolar I disorder to delay the return of depression, mania, hypomania, or mixed episodes. The label also states that Lamictal isn’t recommended for treating an acute manic or mixed episode.

No anxiety disorder is on that list. When a prescriber uses Lamictal for anxiety, it’s off-label. Off-label prescribing is legal, but it means the FDA hasn’t reviewed evidence for that specific use, so the reasoning behind it matters more than usual. Our guide to Lamictal for bipolar disorder covers the approved use in detail.

What the Research Shows for Anxiety

The short answer is that the evidence is thin and depends heavily on what kind of anxiety you mean. A critical review of anticonvulsants in anxiety disorders found the strongest support for pregabalin and gabapentin in some anxiety disorders, and for lamotrigine in PTSD. That PTSD support rests on one very small study.

The table below summarizes the trials discussed in this section. The bottom row reflects our October 2026 PubMed search, which found no placebo-controlled lamotrigine trials for those three conditions.

Condition	Strongest Study	What It Found
PTSD	15-person pilot trial	5 of 10 responded vs. 1 of 4 on placebo
OCD, as an add-on	Small randomized trials	Fewer obsessions and compulsions
Depersonalization disorder	9-person crossover trial	No better than placebo
Borderline personality disorder	276-person trial	No overall benefit at 52 weeks
GAD, panic, social anxiety	No placebo-controlled trials	Unknown

PTSD is where lamotrigine first drew attention. In a pilot trial run at Duke in 1999, 15 adults were randomized, and 5 of the 10 people on lamotrigine responded compared with 1 of 4 on placebo, with gains in re-experiencing and avoidance symptoms. The authors called the results promising and asked for larger trials to confirm them.

OCD has more consistent signals, though only as an add-on. In a 16-week trial of people with treatment-resistant OCD, adding 100 mg of lamotrigine to ongoing serotonin reuptake inhibitor treatment improved obsessions, compulsions, and depressive symptoms compared with placebo in the 33 people who finished. A 2023 meta-analysis of 59 trials found memantine the most effective add-on, followed by lamotrigine, with moderate certainty of evidence. Our guide to medication for OCD explains where these add-ons fit.

Two negative trials matter too. In a crossover trial for depersonalization disorder, lamotrigine did no better than placebo, and none of the nine participants responded. In a UK trial of 276 adults with borderline personality disorder, lamotrigine didn’t improve overall symptoms at 52 weeks. That result is relevant because emotional reactivity is often what people hope Lamictal will calm. A 2026 meta-analysis adds nuance: across smaller trials, lamotrigine reduced anger and hostility in borderline personality disorder, with moderate certainty.

Why Some People Feel Calmer on Lamictal

If the trials are mixed, why do so many people report feeling calmer? The likeliest explanation is that their anxiety is tied to their mood.

A 2006 review describes anxiety disorders as among the most common conditions that occur alongside bipolar disorder. It found no randomized trials in people with both, and suggested that treatment start by stabilizing mood, then add options with proven effects on the specific anxiety disorder. The same review noted that antidepressants, the usual anxiety treatment, carry a risk of switching some people with bipolar disorder into mania.

So when anxiety rises and falls with depressive or hypomanic stretches, steadying the mood may ease the anxiety riding on top of it. That’s a real benefit, but it isn’t the same as Lamictal treating an anxiety disorder directly. If you’re unsure whether your mood shifts fit a bipolar pattern, our guide to bipolar 1 vs. bipolar 2 can help you describe them.

When a Prescriber Might Consider It

Based on the evidence above, Lamictal is most often discussed in a few specific situations:

• Anxiety that occurs alongside bipolar disorder or noticeable mood cycling
• OCD that only partly improved on an adequate SSRI trial, as an add-on
• PTSD symptoms that haven’t responded to first-line options, with honest caveats about the small evidence base
• A history of feeling agitated or “revved up” on antidepressants, which can prompt a closer look at mood

It’s usually a poor fit as a first choice for generalized anxiety, panic, or social anxiety disorder, where well-tested options exist. It’s also a poor fit when you need relief quickly, for reasons the next section explains. Our guide to choosing an anxiety medication walks through the first-line options.

Why Lamictal Takes Weeks to Start

Lamictal can’t be rushed. For adults with bipolar disorder who aren’t taking interacting medications, the label’s schedule is 25 mg daily for weeks 1 and 2, 50 mg daily for weeks 3 and 4, 100 mg in week 5, and 200 mg in week 6. Valproate cuts those doses roughly in half, while some seizure medications raise them.

The slow climb exists to lower the risk of serious rash. The label says nearly all life-threatening rashes have appeared within 2 to 8 weeks of starting, and exceeding the recommended starting dose or escalation raises the risk. That means a fair test of Lamictal for anxiety takes six weeks just to reach a typical dose, plus time at that dose. Our guides to Lamictal dosage and how long Lamictal takes to work cover the timeline in detail.

Risks to Weigh Before Starting

In the bipolar trials, the most common side effects included nausea, insomnia, sleepiness, back pain, fatigue, and rash. Insomnia is worth flagging if you’re taking it for anxiety, since poor sleep can make anxiety worse.

The less common risks are the ones that shape the decision. Each of these comes from the Lamictal label:

• Serious rash, including Stevens-Johnson syndrome (a rare reaction that damages the skin and the lining of the mouth and eyes), occurs in about 0.08% to 0.3% of adults, and any new rash should be reported right away
• Estrogen-containing birth control pills lower lamotrigine levels by about 50%, and levels can rise during the pill-free week
• People with significant heart disease face a possible risk of serious arrhythmias
• Like other antiepileptic drugs, it carries a warning about suicidal thoughts, so mood changes deserve attention
• Stopping suddenly isn’t recommended, and the label advises tapering over at least 2 weeks

Our guide to Lamictal rash explains which rashes need emergency care.

Questions to Ask Your Prescriber

“No one checks in to see if it’s actually working” is one of the most common frustrations with medication care, and with a drug this slow to start, agreeing on a plan up front matters. If Lamictal comes up, these questions can make the conversation more useful:

• What type of anxiety do you think I have, and could mood swings be part of it?
• Have I had a full trial of first-line options at an adequate dose?
• What would “working” look like for me, and when will we check?
• How will this interact with my birth control or other medications?
• What should I do if I notice a rash or a mood change?

If you have thoughts of harming yourself, call or text 988. If you’re in immediate danger, call 911.

This article is for education only and isn’t a substitute for personal medical advice. It reflects sources available as of October 2026. Talk with your own clinician before starting, changing, or stopping any medication.

Get a Clear Read on Your Anxiety

Lamictal may help when anxiety rides on mood instability, but for most anxiety disorders the better-tested path starts elsewhere, so the most useful next step is a clear picture of your symptoms, your mood patterns, and what you’ve already tried. Start your anonymous intake with Siggy. It’s free, asks for no name or email, and lets you describe your anxiety, sleep, and mood in your own words. You’ll get a summary you can download and share with any clinician, and a licensed prescriber reviews every treatment plan before anything is prescribed.